RP-5002

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRP-5002
Drug Alias NamePI3K beta/delta inhibitor (Incozen)RP-5002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase beta inhibitorsPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase betaPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIncozen Therapeutics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncozen Therapeutics Pvt Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A